B Lymphocytes in Autoimmune Disease
自身免疫性疾病中的 B 淋巴细胞
基本信息
- 批准号:10640819
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AffectAffinityAgammaglobulinaemia tyrosine kinaseAntibioticsAntibodiesAntigensArthritisAutoantibodiesAutoimmuneAutoimmune DiseasesAutoimmunityB-Cell Antigen ReceptorB-LymphocytesBacteriaBindingBiological AssayCell physiologyCellsClinicalClonalityComplexCytometryDevelopmentDiseaseDisease OutcomeEnvironmental Risk FactorEventFailureFc ReceptorFundingGeneticHumanImmuneImmune ToleranceImmune systemImmunoglobulin AImmunoglobulin GImmunoglobulin Somatic HypermutationIn VitroIndividualInfectionInflammatoryIntestinesK/BxN modelLeadLinkMalignant NeoplasmsMediatingMicrobeModelingMolecularMucosal ImmunityMucous MembraneMusMyelogenousMyeloid Cell ActivationMyeloid CellsOrganOrganismOutcomePatientsPeyer&aposs PatchesPhagocytesPlayProcessProductionReceptor SignalingRheumatoid ArthritisRoleSignal TransductionSignaling ProteinSortingStructure of germinal center of lymph nodeSupporting CellSystemT-LymphocyteTestingTimeTissuesToll-like receptorsTyrosine Kinase InhibitorVeteransWomanWorkadaptive immunityarmautoimmune arthritisautoimmune pathogenesisautoreactivitycommensal bacteriacommensal microbescytokineexperimental studyfightingfunctional disabilitygut bacteriagut microbesgut microbiomehumoral immunity deficiencyimmunoregulationmicrobiomemonocytenovelperipheral bloodpreventprotective effect
项目摘要
Rheumatoid arthritis (RA) results from a complex cascade of events that breaks immune
tolerance and culminates in the destruction of synovial tissue. Both genetic and environmental
factors contribute to disease. B lymphocytes (B cells) play a critical role, producing the
autoantibodies that trigger arthritis. The Kendall lab works toward understanding B cells that
support arthritis development. We originally used mice deficient in the B cell signaling protein
Bruton’s tyrosine kinase (BTK) to test its role in the K/BxN model of spontaneous autoimmune
arthritis. The studies indicated significant disease protection, accompanied by loss of
autoantibodies, with relative sparing of total IgG. In the course of this work, we made the new
discovery that BTK also affects the gut microbiome, commensal organisms that are thought to
play an important role in the development of autoimmune diseases, including RA. We found that
specialized immune organs in the gut, called Peyer’s patches, are very small, and that they
make low levels of IgA antibody that does not bind gut bacteria as well as it should. Further,
there is dysregulation of the microbiome that may have a protective effect against autoimmune
arthritis. The hypothesis underlying this proposal is that BTK-mediated signaling
supports mucosal immunity and regulates microbes that influence autoimmunity, to be
tested in Aims which: 1) define the IgA repertoire in Btk-deficient versus –sufficient K/BxN mice,
including features such as selection, clonality and evidence of somatic hypermutation, 2)
determine the cell-specific role of BTK in regulating the microbiome, differentiating between B
cell and myeloid cell functions, and 3) determine whether BTK expression and function in
myeloid and B cells differ in RA patients and controls, and whether IgA binding of commensal
bacteria are altered. This project has direct clinical importance in understanding how aberrant B
cells in autoimmune patients may cause microbiome shifts that modulate disease.
类风湿关节炎(RA)是由一系列复杂的事件造成的,这些事件破坏了免疫
耐受性和最终导致滑膜组织的破坏。遗传和环境
因素导致疾病。 B淋巴细胞(B细胞)起着关键作用,产生
引发关节炎的自身抗体。肯德尔实验室致力于了解B细胞
支持关节炎的发展。我们最初使用了缺乏B细胞信号蛋白的小鼠
布鲁顿的酪氨酸激酶(BTK)测试其在赞助自动免疫的K/BXN模型中的作用
关节炎。研究表明,通过丢失而实现了明显的疾病保护
自身抗体,总IgG相对保留。在这项工作的过程中,我们制作了新的
发现BTK还会影响肠道微生物组,共生生物,被认为是
在包括RA在内的自身免疫性疾病的发展中起着重要作用。我们发现
肠道中的专门免疫器官,称为佩耶的斑块,很小,它们
制作低水平的IgA抗体,该抗体不会尽其所能结合肠道细菌。此外,
微生物组的失调可能对自身免疫有保护作用
关节炎。该提案的基础假设是BTK介导的信号传导
支持粘膜免疫学并调节影响自身免疫性的微生物
在目的中测试的目的:1)定义BTK缺陷与k/bxn小鼠的IgA曲目,
包括选择,克隆性和躯体过度突击的证据等特征,2)
确定BTK在调节微生物组中的细胞特异性作用,并区分B
细胞和髓样细胞功能,3)确定BTK表达和功能是否在
RA患者和对照组的髓样和B细胞不同,以及IgA的结合是否存在
细菌改变。该项目在理解异常b中的直接临床重要性
自身免疫性患者的细胞可能会导致调节疾病的微生物组转移。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Btk Supports Autoreactive B Cell Development and Protects against Apoptosis but Is Expendable for Antigen Presentation.
- DOI:10.4049/jimmunol.2000558
- 发表时间:2021-12-15
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peggy L Kendall其他文献
Peggy L Kendall的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peggy L Kendall', 18)}}的其他基金
Bruton's Tyrosine Kinase and Immune Tolerance in Type 1 Diabetes
布鲁顿酪氨酸激酶和 1 型糖尿病的免疫耐受
- 批准号:
10059473 - 财政年份:2019
- 资助金额:
-- - 项目类别:
Bruton's Tyrosine Kinase and Immune Tolerance in Type 1 Diabetes
布鲁顿酪氨酸激酶和 1 型糖尿病的免疫耐受
- 批准号:
8583319 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Bruton's Tyrosine Kinase and Immune Tolerance in Type 1 Diabetes
布鲁顿酪氨酸激酶和 1 型糖尿病的免疫耐受
- 批准号:
8215848 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Bruton's Tyrosine Kinase and Immune Tolerance in Type 1 Diabetes
布鲁顿酪氨酸激酶和 1 型糖尿病的免疫耐受
- 批准号:
8042106 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Bruton's Tyrosine Kinase and Immune Tolerance in Type 1 Diabetes
布鲁顿酪氨酸激酶和 1 型糖尿病的免疫耐受
- 批准号:
8386669 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Bruton's Tyrosine Kinase and Immune Tolerance in Type 1 Diabetes
布鲁顿酪氨酸激酶和 1 型糖尿病的免疫耐受
- 批准号:
8776292 - 财政年份:2011
- 资助金额:
-- - 项目类别:
Bruton's Tyrosine Kinase and Immune Tolerance in Type 1 Diabetes
布鲁顿酪氨酸激酶和 1 型糖尿病的免疫耐受
- 批准号:
8886719 - 财政年份:2011
- 资助金额:
-- - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A platform to identify in vivo targets of covalent cancer drugs in 3D tissues
识别 3D 组织中共价癌症药物体内靶标的平台
- 批准号:
10714543 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Investigating Resistance Mechanisms to Non-covalent Bruton's Tyrosine Kinase Inhibitors and Therapeutic Approaches to Overcome Resistance for Patients with B-Cell Malignancies
研究非共价布鲁顿酪氨酸激酶抑制剂的耐药机制以及克服 B 细胞恶性肿瘤患者耐药性的治疗方法
- 批准号:
10537252 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Investigating Resistance Mechanisms to Non-covalent Bruton's Tyrosine Kinase Inhibitors and Therapeutic Approaches to Overcome Resistance for Patients with B-Cell Malignancies
研究非共价布鲁顿酪氨酸激酶抑制剂的耐药机制以及克服 B 细胞恶性肿瘤患者耐药性的治疗方法
- 批准号:
10781906 - 财政年份:2022
- 资助金额:
-- - 项目类别: